Creative Planning Gossamer Bio, Inc. Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$8.3 - $13.59 $109,742 - $179,686	-13,222 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$11.3 - $14.75 $149,408 - $195,024	13,222 New	13,222 $164,000
Q2 2020 Jul 23, 2020	SELL	$9.52 - $15.98 $114,240 - $191,760	-12,000 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$17.58 - $23.97 $210,959 - $287,640	12,000 New	12,000 $260,000

116

163M

821K

557K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $132M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.